At this year's Canadian Cannabis Awards, a Toronto event that was hosted by the city's own Lift Co., Organigram's 'Wabanaki' was crowned the "Top Sativa Flower," with Aurora's 'Warwick 2 ' coming in second place, and MedReleaf's 'Luminarium' coming in third.
The strain has received glowing reviews on Lift Co.'s site, due to the clear-headed high that it offers, as well as it's ability to help facilitate creative thought. Doctors tend to prescribe the strain to patients who are dealing with depression, PTSD, chronic pain, stress, and insomnia. As the strain doesn't hinder one's energy levels at all, it can be consumed in the morning or afternoon to help consumers overcome the issues that they medicate for.
What's Driving This Trend
- Clear-headed High
- Disruptive innovation opportunity: Develop new strains with a similar clear-headed high effect to cater to consumers who want to medicate without feeling lethargic.
- Facilitate Creative Thought
- Disruptive innovation opportunity: Create cannabis products that specifically target creative individuals and enhance their creative thinking process.
- Medication for Mental Health
- Disruptive innovation opportunity: Explore the development of cannabis strains specifically tailored to address mental health issues such as depression, PTSD, and stress.
Who This Affects Most
- Cannabis Cultivation
- Disruptive innovation opportunity: Implement advanced cultivation techniques to consistently produce strains with desired effects.
- Pharmaceuticals
- Disruptive innovation opportunity: Investigate the use of cannabis-based medications for treating mental health disorders, chronic pain, and insomnia.
- Wellness and Lifestyle
- Disruptive innovation opportunity: Incorporate cannabis products into wellness and lifestyle offerings, such as yoga, meditation, and stress relief programs.
